Table 4 Value of life in Canada
No | Area | Source | Relevance | Type of estimate | Stated value (CA$) | Year | 2019/2020 Value* (CA$) | VOLY (CA$) | VSL (CA$) | QALY (CA$) |
|---|---|---|---|---|---|---|---|---|---|---|
1 | Health | PMPRB | Estimate of the lower bound of the QALY threshold range | QALY | 50,000 | 2019 | 50,000 | 45,998 | 1,683,060 | 50,000 |
2 | Health | PMPRB | Estimate of the upper bound of the QALY threshold range (oncology drugs) | QALY | 100,000 | 2019 | 100,000 | 91,996 | 3,366,119 | 100,000 |
3 | Health | Skedgel et al | Academic estimate of an implied threshold for pCODR (oncology drugs) | QALY | 140,000 | 2018 | 140,000 | 128,794 | 4,712,567 | 140,000 |
4 | Health | PMPRB | Proposed future threshold value | QALY | 60,000 | 2020 | 60,000 | 55,198 | 2,019,672 | 60,000 |
5 | Transport | TBS | Estimate for use in cost–benefit analysis | VSL | 6,110,000 | 2004 | 8,079,656 | 260,912 | 8,079,656 | 283,612 |
6 | Environment | TBS | Estimate for use in cost–benefit analysis | VSL | 6,110,000 | 2004 | 8,079,656 | 260,912 | 8,079,656 | 283,612 |